MSAM
GMAB icon

Moloney Securities Asset Management’s Genmab GMAB Stock Holding History

Moloney Securities Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,604
Closed -$338K – 477
2023
Q4 		$338K Sell
10,604
-12,100
-53% -$380K 0.05% 319
2023
Q3 		$801K Sell
22,704
-7,500
-25% -$286K 0.14% 177
2023
Q2 		$1.15M Buy
+30,204
New +$1.2M 0.2% 126
2021
Q4 		– Sell
-4,736
Closed -$207K – 454
2021
Q3 		$207K Sell
4,736
-424
-8% -$19K 0.04% 388
2021
Q2 		$211K Buy
+5,160
New +$199K 0.04% 390
2020
Q3 		– Sell
-39,900
Closed -$1.35M – 335
2020
Q2 		$1.35M Buy
39,900
+30,150
+309% +$822K 0.39% 82
2020
Q1 		$207K Sell
9,750
-1,500
-13% -$33.4K 0.07% 245
2019
Q4 		$251K Sell
11,250
-500
-4% -$10.9K 0.08% 283
2019
Q3 		$238K Buy
+11,750
New +$231K 0.08% 270

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moloney Securities Asset Management's GMAB Position: Q1 2024 in Review

Moloney Securities Asset Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 10,604 shares — an estimated $338K sold.

Moloney Securities Asset Management first reported a position in GMAB in Q3 2019 and held it in 9 quarters. The position peaked at $1.35M in Q2 2020. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • Moloney Securities Asset Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • Moloney Securities Asset Management sold 10,604 Genmab shares in Q1 2024, an estimated $338K.
  • Moloney Securities Asset Management first reported a position in Genmab in Q3 2019 and held it in 9 quarters.
  • Moloney Securities Asset Management's Genmab position peaked at $1.35M in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Moloney Securities Asset Management's 13F filing for Q1 2024, filed 1 May 2024.